A R Neurath|N Strick - JoVE Visualize

Showing results (51-60 of 93) with videos related to

Pageof 10

Sort By:

American Journal of Epidemiology|February 1, 1981

Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populationsW Szmuness, A R Neurath, C E Stevens, et al.

The Journal of General Virology|March 1, 1978

Radioimmunoassay and some properties of human antibodies to hepatitis B core antigenA R Neurath, W Szmuness, C E Stevens, et al.

The Journal of General Virology|March 1, 1979

Radioimmunoassay of hepatitis B e-antigen (HBeAg): identification of HBeAg not associated with immunoglobulinsA R Neurath, N Strick, W Szmuness, et al.

Nature|May 9, 1985

Hepatitis B virus contains pre-S gene-encoded domainsA R Neurath, S B Kent, N Strick, et al.

Journal of Medicinal Chemistry|April 15, 1994

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1A K Debnath, S Jiang, N Strick, et al.

Peptide Research|July 1, 1992

Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. II. Region S(122-136)M W Pride, Y M Thanavala, N Strick, et al.

Molecular Immunology|September 1, 1991

Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)--II. Synthetic peptides linked to HIV-1 carrier proteins gag and nefA R Neurath, N Strick, H Kolbe, et al.

Journal of Molecular Recognition : JMR|September 1, 1995

Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxisA R Neurath, A K Debnath, N Strick, et al.

Nature Medicine|February 1, 1996

Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIVA R Neurath, S Jiang, N Strick, et al.

Antimicrobial Agents and Chemotherapy|December 24, 2004

Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammationR N Fichorova, F Zhou, V Ratnam, et al.

Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:

Pageof 10

American Journal of Epidemiology|February 1, 1981

Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populationsW Szmuness, A R Neurath, C E Stevens, et al.

The Journal of General Virology|March 1, 1978

Radioimmunoassay and some properties of human antibodies to hepatitis B core antigenA R Neurath, W Szmuness, C E Stevens, et al.

The Journal of General Virology|March 1, 1979

Radioimmunoassay of hepatitis B e-antigen (HBeAg): identification of HBeAg not associated with immunoglobulinsA R Neurath, N Strick, W Szmuness, et al.

Nature|May 9, 1985

Hepatitis B virus contains pre-S gene-encoded domainsA R Neurath, S B Kent, N Strick, et al.

Journal of Medicinal Chemistry|April 15, 1994

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1A K Debnath, S Jiang, N Strick, et al.

Peptide Research|July 1, 1992

Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. II. Region S(122-136)M W Pride, Y M Thanavala, N Strick, et al.

Molecular Immunology|September 1, 1991

Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)--II. Synthetic peptides linked to HIV-1 carrier proteins gag and nefA R Neurath, N Strick, H Kolbe, et al.

Journal of Molecular Recognition : JMR|September 1, 1995

Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxisA R Neurath, A K Debnath, N Strick, et al.

Nature Medicine|February 1, 1996

Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIVA R Neurath, S Jiang, N Strick, et al.

Antimicrobial Agents and Chemotherapy|December 24, 2004

Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammationR N Fichorova, F Zhou, V Ratnam, et al.

Pageof 10